Assuming merck is required, the following results were found.

  • Novartis, Merck and Allergan join those raising U.S. drug prices for 2020 - Reuters

    NEW YORK (Reuters) - Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by...

    https://mschristian.org/index.php/blog/novartis-merck-and-allergan-join-those-raising-u-s-drug-prices-for-2020-reuters
  • Lower LDL Longer Is Better for Stroke Prevention

    group concluded. Disclosures The Treat Stroke to Target trial received unrestricted grants from Pfizer, AstraZeneca, and Merck as well as funding from the French Ministry of Health and SOS-Attaque Cérébrale Association. Amarenco reported research grant...

    https://mschristian.org/index.php/blog/lower-ldl-longer-is-better-for-stroke-prevention
  • Global Multiple Sclerosis Market by Types, Applications, Countries, Companies and Forecasts to 2024 covered in a Latest Research - Market Research Reporting

    is dominate by companies like Abbvie, Acorda Therapeutics, Bayer HealthCare, Biogen, Genzyme (Sanofi), GlaxoSmithKline, Merck Serono, Novartis, Pfizer, Teva and others which are profiled in this report as well in terms of Sales, Price, Revenue, Gross...

    https://mschristian.org/index.php/blog/global-multiple-sclerosis-market-by-types-applications-countries-companies-and-forecasts-to-2024-covered-in-a-latest-research-market-research-reporting
  • Demyelinating Risks With Anti-TNF Vary in Rheumatic Diseases - MedPage Today

    Research Fund Denmark, and the KarolinskaInstitute. The authors reported financial relationships with Novartis, Biogen, Merck, Sanofi Genzyme, Teva, Biogen, Roche, AbbVie, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Pfizer, Samsung Bioepis,...

    https://mschristian.org/index.php/blog/demyelinating-risks-with-anti-tnf-vary-in-rheumatic-diseases-medpage-today
  • Bad News for Tau PET Tracer in CTE

    relevant relationships with the Alzheimer's Association, the Global Brain Health Institute, NIH, Quest Diagnostics, the Merck Foundation, the Centers for Medicare and Medicaid Innovation, Avid Radiopharmaceuticals, Eli Lilly, Tau Consortium, GE...

    https://mschristian.org/index.php/blog/bad-news-for-tau-pet-tracer-in-cte
  • Despite Intense Public, Congressional Scrutiny, Pharma Still Hikes Prices For Hundreds Of Drugs In 2020 - Kaiser Health News

    deals with several other drug makers to delay competition in the U.S. until 2023. (Silverman, 1/2) Some key drugs, such as Merck & Co.’s top-selling cancer drug Keytruda, have yet to see higher prices, according to data compiled by Evercore ISI’s Umer...

    https://mschristian.org/index.php/blog/despite-intense-public-congressional-scrutiny-pharma-still-hikes-prices-for-hundreds-of-drugs-in-2020-kaiser-health-news
  • MS Therapies Among Limited Offerings Through AllianceRx Walgreens Prime

    secondary progressive MS (SPMS). Mayzent is manufactured by Novartis. #Mavenclad, manufactured by EMD Serono (known as Merck KGaA outside the U.S. and Canada), was approved by the FDA (also in March) for RRMS and active SPMS. Because of its safety...

    https://mschristian.org/index.php/blog/ms-therapies-among-limited-offerings-through-alliancerx-walgreens-prime
  • Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress - BioSpace

    potential additional tab-cel® indications are also advancing -- A Phase 1/2 clinical study of tab-cel® in combination with Merck's anti-PD-1 (programmed death receptor-1) therapy, KEYTRUDA® (pembrolizumab), in patients with platinum-resistant or...

    https://mschristian.org/index.php/blog/atara-biotherapeutics-announces-third-quarter-2019-financial-results-and-recent-clinical-operational-and-strategic-progress-biospace
  • Hopes for Novel Stroke Drug Dashed in Trial

    Innovates, and NoNO. Hill disclosed relationships with the Canadian Institutes for Health Research, Alberta Innovates, NoNO, Merck, Hoffmann-La Roche Canada, Covidien (Medtronic), Boehringer-Ingelheim, Stryker, Medtronic, a patent for systems and...

    https://mschristian.org/index.php/blog/hopes-for-novel-stroke-drug-dashed-in-trial
  • Rare Shrew-Borne Illness Tied to Fatal Encephalitis

    no relevant relationships with industry. One co-author disclosed support from GlaxoSmithKline, Sanofi, Roche, Pfizer, Merck Sharp & Dohme, and Gilead. Honda disclosed no relevant relationships with industry. 2020-01-07T18:30:00-0500 Original link

    https://mschristian.org/index.php/blog/rare-shrew-borne-illness-tied-to-fatal-encephalitis
  • Multiple Sclerosis Market: Global Product Intelligence, Analysis, Opportunities and Forecast to 2025 - Press Release - Digital Journal

    Landscape The leading players in the global multiple sclerosis market are Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Merck & Co. Inc., AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi Aventis, Biogen Idec, F....

    https://mschristian.org/index.php/blog/multiple-sclerosis-market-global-product-intelligence-analysis-opportunities-and-forecast-to-2025-press-release-digital-journal
  • Global Multiple Sclerosis Drugs Production Market Share, Revenue, and Average Price by Manufacturers Shared in a Latest Research Report - Market Research Writeup

    Europe, China and Japan. Key companies profiled in Multiple Sclerosis Drugs Marketreport are Biogen, Sanofi, Novartis, Teva, Merck Kgaa, Bayer, Acorda, Mallinckrodt and more in term of company basic information, Product Introduction, Application,...

    https://mschristian.org/index.php/blog/global-multiple-sclerosis-drugs-production-market-share-revenue-and-average-price-by-manufacturers-shared-in-a-latest-research-report-market-research-writeup
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    payersin the electronic drug delivery system market are AstraZeneca, Insulet Corporation, Medtronic,F.Hoffmann-La Roche Ltd, Merck Group, Amgen, Bayer AG, Companion Medical, Tandem Diabetes Care, and Novo Nordisk A/S. Research & development activities...

    https://mschristian.org/index.php/blog/electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance

Results 1 - 13 of 13
 
 

Follow Us on Twitter

Follow Us On Twitter - Image